Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Terumo Corporation

Market Cap 3,281B 20.31B 17.73B 16.42B 15.39B 28.8B 1,918B 29.02B 193B 75.4B 944B 76.33B 74.71B P/E 2026
22.9x
P/E 2027 * 19.6x
Enterprise Value 3,419B 21.17B 18.47B 17.11B 16.04B 30.01B 1,999B 30.23B 201B 78.57B 984B 79.53B 77.84B EV / Sales 2026
2.75x
EV / Sales 2027 * 2.71x
Free-Float
97.07%
Yield 2026
1.42%
Yield 2027 * 1.6%
Manager TitleAgeSince
Chief Executive Officer 62 2024-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 2022-03-31
Director/Board Member 63 2019-06-20
Director/Board Member 75 2020-06-24
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+3.03% - - 20.35B
-0.10%+0.26%-33.52%-17.14% 154B
+1.54%-1.07%-8.11%-10.79% 102B
-4.45%+3.12%+61.36%+57.49% 56.51B
-1.90%-3.49%-7.43%+47.34% 52.89B
+1.67%-1.55%-14.51%-43.86% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-9.41%-44.24% 27.96B
+1.35%-0.26%+51.96%-10.42% 23.17B
+1.61%-2.38%-14.03%-5.14% 19.75B
Average +0.13%-1.67%+3.29%-3.35% 56.21B
Weighted average by Cap. -0.09%-1.37%-5.94%-2.74%

Financials

2026 2027 *
Net sales 1,118B 6.92B 6.04B 5.59B 5.24B 9.81B 653B 9.88B 65.82B 25.68B 322B 26B 25.44B 1,237B 7.66B 6.68B 6.19B 5.8B 10.85B 723B 10.94B 72.84B 28.42B 356B 28.77B 28.16B
Net income 137B 847M 739M 685M 642M 1.2B 79.98B 1.21B 8.06B 3.14B 39.38B 3.18B 3.12B 166B 1.03B 895M 828M 777M 1.45B 96.8B 1.46B 9.75B 3.81B 47.66B 3.85B 3.77B
Net Debt 138B 853M 744M 689M 646M 1.21B 80.53B 1.22B 8.11B 3.17B 39.65B 3.2B 3.14B 75.69B 469M 409M 379M 355M 664M 44.24B 669M 4.46B 1.74B 21.78B 1.76B 1.72B
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!